Skip to main content
Top
Published in: Pituitary 2/2006

01-06-2006

Two years of growth hormone replacement therapy in a group of patients with Sheehan’s syndrome

Authors: Débora Vieira Soares, Luciana Diniz Carneiro Spina, Rosane Resende de Lima Oliveira Brasil, Priscila Marise Lobo, Elizabeth Salles, Claúdia Medina Coeli, Flávia Lúcia Conceição, Mario Vaisman

Published in: Pituitary | Issue 2/2006

Login to get access
Metadata
Title
Two years of growth hormone replacement therapy in a group of patients with Sheehan’s syndrome
Authors
Débora Vieira Soares
Luciana Diniz Carneiro Spina
Rosane Resende de Lima Oliveira Brasil
Priscila Marise Lobo
Elizabeth Salles
Claúdia Medina Coeli
Flávia Lúcia Conceição
Mario Vaisman
Publication date
01-06-2006
Publisher
Kluwer Academic Publishers
Published in
Pituitary / Issue 2/2006
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-006-9990-9

Other articles of this Issue 2/2006

Pituitary 2/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine